
Triveni Bio
Developer of a clinical-stage biotechnology company designed to create antibody-based therapies targeting immunological and inflammatory diseases. The company offers a genetics-informed antibody disco...
Valuation
$310M
Latest known
Share Price
N/A
Total Raised
$231.6M
Last Round
N/A